ATRC AtriCure, Inc.

54.11USD-2.42%Mkt Cap: 2.76B USDP/E: 174.55

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap2.76B USD
Enterprise Value2.73B USD
Revenue (TTM)589.80M USD
Gross Profit400.78M USD
Net Income (TTM)-11.45M USD
Revenue/Share12.17 USD
Last Price54.11 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)174.55
P/E (Forward)119.30
PEG10.00
EV/EBITDA71.56
EV/Revenue4.63
P/S4.67
P/B5.17
EPS (TTM)0.31 USD
EPS (Forward)0.46 USD
52W Range
25.3771% of range66.02
52W High66.02 USD
52W Low25.37 USD
Profitability
Gross Margin74.98%
Oper. Margin2.89%
EBITDA Margin6.48%
Profit Margin-2.14%
ROE-2.33%
ROA-1.75%
ROIC-2.37%
ROCE-1.65%
Growth
Revenue Growth15.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF57.33M USD
CapEx (TTM)15.05M USD
FCF Margin6.30%
FCF Yield1.35%
Net Debt-90.20M USD
Net Debt/EBITDA-2.36
Net Debt/FCF-2.43
Balance Sheet
Debt/Equity0.15
Current Ratio4.33
Quick Ratio3.13
Book Value/Sh10.47 USD
Cash/Share3.67 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)64.89 USD
Upside (mean)+19.9%
Target Range50.00 USD – 70.00 USD
50.00+19.9% to mean70.00
# Analysts9
Ownership
Shares Out.50.92M
Float48.89M
Insiders3.73%
Institutions112.72%
Short Interest
Short Ratio6.0d
Short % Float10.00%
Short % Out.9.60%
Shares Short4.89M
Short (prev mo.)4.82M
Technical
SMA 5057.56 (-6.0%)
SMA 20039.18 (+38.1%)
Beta1.21
S&P 52W Chg12.08%
Avg Vol (30d)736.74K
Avg Vol (10d)871.41K
Technical Indicators
RSI (14)40.9
MACD-0.6016
MACD Signal0.2118
MACD Hist.-0.8134
BB Upper64.90 USD
BB Middle58.83 USD
BB Lower52.76 USD
BB Width20.62%
ATR (14)2.559 USD
Vol Ratio (20d)0.63x

About AtriCure (NASDAQ: ATRC)

›

AtriCure (NASDAQ: ATRC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 1,350 employees.

The shares were at 54.11 USD on 19 November 2026, up 71.8% over 52 weeks. Its 52-week range is 25.37 USD to 66.02 USD: the price is 18.0% below the high and 113.3% above the low.

At a market capitalisation of 2.76B USD, it trades at 174.5 times trailing earnings and 119.3 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a premium of 254% for ATRC.

AtriCure reports return on equity of -2.3%, an operating margin of 2.9% and revenue up 15.0% year over year.

It holds more cash than debt, a net cash position of 90.20M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 9 analysts cover the stock, with an average rating of Buy; their mean price target of 64.89 USD is 19.9% above the current price. The next earnings report is expected on 16 February 2027.